Occasional antiphospholipid antibody positive patients with recurrent pregnancy loss also merit aspirin therapy: A retrospective cohort-control study

American Journal of Reproductive Immunology

Volumn 59, Issue 3, 2008, Pages 235-241

  Sugiura Ogasawara, Mayumi ^a   Ozaki, Yasuhiko ^a   Nakanishi, Tamao ^a   Sato, Takeshi ^a   Suzumori, Nobuhiro ^a   Kumagai, Kyoko ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

2 glycoprotein I dependent anticardiolipin antibody; Antiphospholipid syndrome; Lupus anticoagulant; Recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; FEMALE; HUMAN; KARYOTYPING; LIVE BIRTH; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ASPIRIN; BETA 2-GLYCOPROTEIN I; COHORT STUDIES; FEMALE; HUMANS; LUPUS COAGULATION INHIBITOR; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY, HIGH-RISK; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 39149131394     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00570.x     Document Type: Article

References (29)

1. Farquharson RG, Pearson JF, John L: Lupus anticoagulant and pregnancy management. Lancet 1984; 28:228-229.
2. Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A: Reproductive impact of congenital Mullerian anomalies. Hum Reprod 1997; 12:2277-2281.
3. Sugiura-Ogasawara M, Ozaki Y, Sato T, Suzumori N, Suzumori K: Poor prognosis of recurrent aborters with either maternal or paternal reciprocal translocation. Fertil Steril 2004; 81:367-373.
4. Nelen W, Steegers E, Eskes T, Blom H: Genetic risk factors for unexplained recurrent pregnancy loss. Lancet 1996; 350:861.
5. Rey E, Kahn SR, David M, Shrier I: Thrombophilic disorders and fetal loss: A meta-analysis. Lancet 2003; 361:901-908.
6. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Yagami Y, Gleicher N: Elevated natural killer cell activity at preconception as a predictor of a subsequent miscarriage: A prospective cohort study. Lancet 1995; 345:1342-1344.
7. Ogasawara MS, Aoki K, Katano K, Ozaki Y, Suzumori K: Factor XII but not protein C, protein S, antithrombin III or factor XIII as a predictor of recurrent miscarriage. Fertil Steril 2001; 75:916-919.
8. Sugiura-Ogasawara M, Nozawa K, Nakanishi T, Hattori Y, Ozaki Y: Complement as a predictor of further miscarriage in couples with recurrent miscarriages. Hum Reprod 2006; 21:2711-2714.
9. Ogasawara M, Aoki K, Kajiura S, Yagami Y: Are antinuclear antibodies predictive of recurrent miscarriage? Lancet 1996; 347:1183-1184.
10. Herz-Picciotto I, Samuels SJ: Incidence of early pregnancy loss of pregnancy. N Engl J Med 1996; 319:1483-1484.
11. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42:1309-1311.
12. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA: International consensus statement of an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4:295-306.
13. Rai R, Cohen H, Dave M, Regan L: Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-257.
14. Rai R, Backos M, Baxter N, Chilcott I, Regan L: Recurrent miscarriage - an aspirin a day? Hum Reprod 2000; 15:2220-2223.
15. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T: Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179:457-462.
16. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y: Anti β2glycoprotein I antibodies and lupus anticoagulant in patients with recurrent pregnancy loss; prevalence and clinical association. Lupus 1996; 5:587-592.
17. Brandt JT: Assays for phospholipid-dependent formation of thrombin and Xa: A potential method for quantifying lupus anticoagulant activity. Thromb Haemost 1991; 66:453-458.
18. Empson M, Lassere M, Craig JC, Scott JR: Recurrent pregnancy loss with antiphospholipid antibody: A systematic review of therapeutic trials. Obstet Gynecol 2002; 99:135-144.
19. Sebire NJ, Backos M, Goldin RD, Regan L: Placental massive perivillous fibrin deposition associated with antiphospholipid antibody syndrome. BJOG 2002; 109:570-573.
20. Rand JH, Wu X, Anderee HAM, Lockwood CJ, Guller S, Scher J, Harpel PC: Pregnancy loss in the antiphospholipid antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337:154-160.
21. Ogasawara M, Aoki K, Matsuura E, Kunimatsu M, Ohkubo I, Galli M, Sasaki M, Yagami Y: Anticardiolipin antibodies in patients with pregnancy loss induce factor Xa production in the presence of β2-glycoprotein I. Am J Reprod Immunol 1995; 34:269-273. I
22. Quenby S, Mountfield S, Cartwright JE, Whitley GS, Chamley L, Vince G: Antiphospholipid antibodies prevent extravillous trophoblast differentiation. Fertil Steril 2005; 83:691-698.
23. Bose P, Black S, Kadyrov M, Bartz C, Shlebak A, Regan L, Huppertz B: Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro. Am J Obstet Gynecol 2004; 191:2125-2131.
24. Holers VM, Girardi G, Mo L, Guthridge JM, Molina H, Pierangeli SS, Espinola R, Xiaowei LE, Mao D, Vialpando CG, Salmon JE: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002; 195:211-220.
25. Girardi G, Redecha P, Salmon JE: Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 2004; 10:1222-1226.
26. Stern JJ, Cerrillo M, Dorfmann AD, Coulam CB, Gutieerrez-Najar AJ: Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65:250-253.
27. Ogasawara M, Aoki K, Okada S, Suzumori K: Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73:300-304.
28. Aldrich CL, Stephenson MD, Karrison T et.al.: HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001; 7:1167-1172.
29. Tsukishiro S, Li QY, Tanemura M, Sugiura-Ogasawara M, Suzumori K, Sonta SI: Paternal uniparental disomy of chromosome 14 and unique exchange of chromosome 7 in cases of spontaneous abortion. J Hum Genet 2005; 4:112-117.